---  
layout: startup_page  
title: "Timberlyne Therapeutics"  
id: "timberlynetx.com"  
permalink: "/timberlynetherapeuticstimberlynetx.com01092025/"  
website: "https://timberlyne-tx.com"  
funding_round: "Series A"  
funding_amount: "$180M"  
investors: "Abingworth, Bain Capital Life Sciences, Venrock Healthcare Capital Partners, Boyu Capital, Lilly Asia Ventures, Braidwell LP, 3H Health Investment"  
about: "Timberlyne Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for autoimmune disorders. Their lead program, CM313, is a monoclonal antibody targeting CD38, showing promising results in treating various autoimmune diseases and cancers. The company was formed through a partnership between Mountainfield Venture Partners and Keymed Biosciences."  
markets: "Biopharma, Biotechnology, Health Care"  
hq: "San Diego, California, United States"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/timberlyne-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/timberlyne-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/731899-81"  

date_display: "09-Jan-2025"  
date: "2025-01-09"

# SEO Optimization  
meta_title: "Timberlyne Therapeutics - Series A Funding ($180M)"  
meta_description: "Timberlyne Therapeutics, Timberlyne Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for autoimmune disorders. Their lead program, CM313, ..."  
meta_keywords: "Timberlyne Therapeutics, Biopharma, Biotechnology, Health Care, Series A funding"  
canonical_url: "https://startup.projectstartups.com/timberlynetherapeuticstimberlynetx.com01092025/"  
---